Skip to main content
SpringerLink
Log in

Die B-Zelle in der Typ-I-Allergie

Serie: Das kleine 1x1 der Immunologie — Teil 3

  • Im Fokus
  • In Focus
  • Published:
Allergo Journal Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Burton OT, Oettgen HC. Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases. Immunol Rev; 242: 128-43

  2. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol. 2003; 3: 721–32

    Article  PubMed  CAS  Google Scholar 

  3. Francis JN, James LK, Paraskevopoulos G, et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol. 2008; 121: 1120–5 e1122

    Article  PubMed  CAS  Google Scholar 

  4. Dorner T, Radbruch A, Burmester GR. B-cell-directed therapies for autoimmune disease. Nat Rev Rheumatol. 2009; 5: 433–41

    Article  PubMed  Google Scholar 

  5. Radbruch A, Muehlinghaus G, Luger EO, et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol. 2006; 6: 741–50

    Article  PubMed  CAS  Google Scholar 

  6. Bouaziz JD, Yanaba K, Venturi GM, et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci U S A. 2007; 104: 20878–83

    Article  PubMed  CAS  Google Scholar 

  7. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008; 28: 639–50

    Article  PubMed  CAS  Google Scholar 

  8. Goetz M, Atreya R, Ghalibafian M, Galle PR, Neurath MF. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis. 2007; 13: 1365–8

    Article  PubMed  Google Scholar 

  9. Dass S, Vital EM, Emery P. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum. 2007; 56: 2715–8

    Article  PubMed  CAS  Google Scholar 

  10. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006; 176: 705–10

    PubMed  CAS  Google Scholar 

  11. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002; 3: 944–50

    Article  PubMed  CAS  Google Scholar 

  12. Neves P, Lampropoulou V, Calderon-Gomez E, et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity. 2010; 33: 777–90

    Article  PubMed  CAS  Google Scholar 

  13. Vallerskog T, Gunnarsson I, Widhe M, et al. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol. 2007; 122: 62–74

    Article  PubMed  CAS  Google Scholar 

  14. Simon D, Hosli S, Kostylina G, Yawalkar N, Simon HU. Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol. 2008; 121: 122–8

    Article  PubMed  CAS  Google Scholar 

  15. Alexander T, Thiel A, Rosen O, et al. Depletion of autoreactive immunological memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood. 2008

  16. Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 2006; 6: 761–71

    Article  PubMed  CAS  Google Scholar 

  17. Heine G, Anton K, Henz BM, Worm M. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur J Immunol 2002; 32: 3395–404

    PubMed  CAS  Google Scholar 

  18. Milovanovic M, Heine G, Hallatschek W, Opitz B, Radbruch A, Worm M. Vitamin D receptor binds to the epsilon germline gene promoter and exhibits transrepressive activity. J Allergy Clin Immunol. 2010; 126: 1016–23, 1023.e1-4

    Article  PubMed  CAS  Google Scholar 

  19. Heine G, Niesner U, Chang HD, et al. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol 2008; 38: 2210–8

    Article  PubMed  CAS  Google Scholar 

  20. Hartmann B, Heine G, Babina M, et al. Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response. Allergy 2011; 66: 540–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Dermatologie, Venerologie und Allergologie, Allergie-Centrum-Charité, Charitéplatz 1, 10117, Berlin, Deutschland

    Franziska Ruëff

Authors
  1. Franziska Ruëff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Franziska Ruëff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruëff, F. Die B-Zelle in der Typ-I-Allergie. Allergo J 21, 466–467 (2012). https://doi.org/10.1007/s15007-012-0441-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15007-012-0441-9

Search

Navigation